Bamboos Health Care Holdings Limited

HKEX:2293.HK

0.65 (HKD) • At close September 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q2
Revenue 49.80459.39668.41867.25973.03672.24437.42434.79237.52643.16722.55336.65818.32946.79623.39838.52819.26436.88329.84428.12226.26126.24123.0120.41617.98716.18415.166
Cost of Revenue 17.332.16617.99244.51523.2620.92717.77717.77718.4458.0914.0459.9164.95811.2475.6249.8784.9397.5027.0496.3275.8835.7556.1084.1533.213.5212.731
Gross Profit 32.50427.2350.42622.74449.77651.31719.64717.01519.08135.07618.50726.74213.37135.54917.77528.6514.32529.38122.79521.79520.37820.48616.90216.26314.77712.66312.435
Gross Profit Ratio 0.6530.4580.7370.3380.6820.710.5250.4890.5080.8130.8210.7290.7290.760.760.7440.7440.7970.7640.7750.7760.7810.7350.7970.8220.7820.82
Reseach & Development Expenses 000000000000000000000000000
General & Administrative Expenses 00.01500.03300.0530-0.04801.4271.427001.0911.091000.72200.78000000.1890
Selling & Marketing Expenses 00.40800.99300.12800.51400.4990.25000.2260.113001.12800.964000000.3970
SG&A 0.0160.4370.0921.0580.1110.2340.0530.4662.73815.2961.6762.5651.2832.4081.2041.020.511.850.6641.7440.780.7890.4340.360.360.7740.242
Other Expenses 0.011-0.7090.585-0.3051.1760.4660.4374.0250.764000000000000000000
Operating Expenses 11.5856.45412.1020.305-1.176-0.466-0.437-4.025-0.76415.2963.77810.1695.0857.7973.8995.8022.9018.853.8045.2924.5424.4075.52413.9063.663.5054.922
Operating Income 22.76821.23539.14922.43950.95251.78320.08421.0419.84527.29414.58317.9088.95428.98914.49522.88411.44220.53118.99116.50315.83616.07911.47614.5611.11712.7857.513
Operating Income Ratio 0.4570.3580.5720.3340.6980.7170.5370.6050.5290.6320.6470.4890.4890.6190.6190.5940.5940.5570.6360.5870.6030.6130.4990.7130.6180.790.495
Total Other Income Expenses Net -1.752-0.691-1.0197.717-8.671-1.8233.525-4.8120.5292.8270.478-0.911-0.456-1.042-0.5210.1360.0680.170.0940.0550.094-0.094-0.216-12.377-0.198-3.847-0.116
Income Before Tax 21.01620.54438.1330.15642.28149.9623.60916.22820.37430.12115.06116.9978.49927.94713.97423.0211.5120.70119.08516.55815.9315.98511.262.18310.9198.9387.397
Income Before Tax Ratio 0.4220.3460.5570.4480.5790.6920.6310.4660.5430.6980.6680.4640.4640.5970.5970.5970.5970.5610.6390.5890.6070.6090.4890.1070.6070.5520.488
Income Tax Expense 3.8934.2067.5495.0298.7888.4993.9592.4293.0576.5193.261.6790.845.3882.6943.3581.6793.6423.5332.9092.7372.8022.0562.2142.1891.6071.662
Net Income 17.12316.33830.58125.12733.49341.31519.70713.816.89123.60211.80115.3187.65922.55911.2819.6629.83117.05915.55213.64913.19313.1839.204-0.0318.737.3315.735
Net Income Ratio 0.3440.2750.4470.3740.4590.5720.5270.3970.450.5470.5230.4180.4180.4820.4820.510.510.4630.5210.4850.5020.5020.4-0.0020.4850.4530.378
EPS 0.0430.0410.0770.0630.0840.10.0490.0350.0420.0590.030.0380.0190.0560.0280.0490.0250.0430.0390.0340.0330.0330.023-00.0290.0490
EPS Diluted 0.0430.0410.0770.0630.0840.10.0490.0350.0420.0590.030.0380.0190.0560.0280.0490.0250.0430.0390.0340.0330.0330.023-00.0290.0490
EBITDA 23.35921.78339.9227.6653.4253.39522.83322.16120.95827.87114.87218.2069.10329.25614.62823.1411.5720.77419.23416.76316.10216.36711.80114.80111.35912.9797.731
EBITDA Ratio 0.4690.3670.5830.4110.7310.7390.610.6370.5580.6460.6590.4970.4970.6250.6250.6010.6010.5630.6440.5960.6130.6240.5130.7250.6320.8020.51